Table 16Characteristics of included studies that compared efficacy or comparative effectiveness between patients having different characteristics or specific trauma types

StudyArm (N)Duration (Followup)Population Trauma TypeBaseline PTSD SeverityaMean Age (Y)% Female% Non-whiteRisk of Bias
Bohus et al., 201323DBT (43)
TAU-WL (39)
24 weeks (post, 6 weeks, 12 weeks)Child abuse survivors
Subgroup analysis: BPD
83 to 8836100NRMedium
Markowitz et al., 2015132, 135PE (38)
IPT (40)
Relaxation (32)
14Chronic PTSD
Mixed
Subgroup analysis: MDD, trauma type, gender, age of primary trauma exposure
68.9 to 72.1407735Medium
Resick et al., 20023
Resick, et al., 2003125
CPT (62)
PE (62)
WL (47)
6 weeks (3 and 9 months)Female
Sexual assault
Subgroup analysis: history of child sexual abuse
69.9 to 76.63210029Medium
van der Kolk et al., 200747EMDR (29)
Fluoxetine (30)
Placebo (29)
8 weeks (6 months)Male and female
Mixed subgroup analysis: child-onset and adult-onset trauma
71.2368333Medium
a

Data reported are mean CAPS totals or range of mean CAPS total scores across groups unless otherwise specified.

BPD = borderline personality disorder; CAPS = Clinician-Administered PTSD Scale; DBT = dialectical behavior therapy; CPT = cognitive processing therapy; EMDR = eye movement desensitization and reprocessing; F = female; IPT = interpersonal therapy; MDD = major depressive disorder; N = total number randomized/assigned to intervention and control groups; PE = prolonged exposure; PTSD = posttraumatic stress disorder; TAU = trauma affect regulation; WL = wait-list; y = year.

From: Results

Cover of Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update
Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update [Internet].
Comparative Effectiveness Review, No. 207.
Forman-Hoffman V, Middleton JC, Feltner C, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.